Archive for March 29th, 2012

CHTP receives CRL for Northera. TELK holds reverse split vote

Mar 29, 2012 No Comments by

Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced today it received a  complete response letter for Northera for the treatment of symptomatic neurogenic orthostatic hypotension (NOH). The FDA requested that the company submit data from an additional trial demonstrating efficacy over a 2- to 3-month period. The company said that this data could possibly come from its ongoing […]

Daily News Read more